Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$536M |
| 2 |
Apple
AAPL
|
+$362M |
| 3 |
Micron Technology
MU
|
+$270M |
| 4 |
Eli Lilly
LLY
|
+$228M |
| 5 |
Cisco
CSCO
|
+$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Tesla
TSLA
|
+$463M |
| 3 |
NVIDIA
NVDA
|
+$424M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Meta Platforms (Facebook)
META
|
+$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
L3Harris
LHX
$52.2B
| $595K | ﹤0.01% |
+2,500
| New | +$595K |
|
2702
Fidelity MSCI Financials Index ETF
FNCL
$2.37B
| $594K | ﹤0.01% |
9,300
+2,900
| +45% | +$185K |
|
2703
Cantaloupe
CTLP
$792M
| $593K | ﹤0.01% |
80,200
-165,900
| -67% | -$1.23M |
|
2704
Gold Resource Corp
GORO
$133M
| $593K | ﹤0.01% |
1,697,529
+201,139
| +13% | +$70.3K |
|
2705
RAPT Therapeutics
RAPT
$268M
| $592K | ﹤0.01% |
36,825
+11,337
| +44% | +$182K |
|
2706
Vanguard Materials ETF
VAW
$2.89B
| $592K | ﹤0.01% |
2,800
+700
| +33% | +$148K |
|
2707
First Mid Bancshares
FMBH
$945M
| $591K | ﹤0.01% |
15,200
+2,200
| +17% | +$85.6K |
|
2708
Cimpress
CMPR
$1.4B
| $590K | ﹤0.01% |
7,200
-10,700
| -60% | -$877K |
|
2709
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.35B
| $590K | ﹤0.01% |
+12,900
| New | +$590K |
|
2710
Pyxis Oncology
PYXS
$113M
| $588K | ﹤0.01% |
160,336
+63,400
| +65% | +$233K |
|
2711
Innospec
IOSP
$2.05B
| $588K | ﹤0.01% |
5,200
-4,000
| -43% | -$452K |
|
|
OPOF
2712
DELISTED
Old Point Financial
OPOF
| $588K | ﹤0.01% |
30,429
+2,300
| +8% | +$44.4K |
|
2713
Champions Oncology
CSBR
$94.2M
| $584K | ﹤0.01% |
119,991
-2,600
| -2% | -$12.7K |
|
|
LFT
2714
Lument Finance Trust
LFT
$121M
| $584K | ﹤0.01% |
230,800
+21,878
| +10% | +$55.4K |
|
2715
BOK Financial
BOKF
$7.06B
| $583K | ﹤0.01% |
5,577
-15,900
| -74% | -$1.66M |
|
|
OMGA
2716
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $579K | ﹤0.01% |
474,600
+346,200
| +270% | +$422K |
|
2717
Aldeyra Therapeutics
ALDX
$324M
| $579K | ﹤0.01% |
107,400
-395,900
| -79% | -$2.13M |
|
|
SY
2718
So-Young International
SY
$374M
| $579K | ﹤0.01% |
615,528
-16,100
| -3% | -$15.1K |
|
2719
Digimarc
DMRC
$204M
| $578K | ﹤0.01% |
21,500
-200
| -0.9% | -$5.38K |
|
2720
INmune Bio
INMB
$53.4M
| $578K | ﹤0.01% |
+107,200
| New | +$578K |
|
2721
LINKBANCORP
LNKB
$268M
| $577K | ﹤0.01% |
90,000
+65,400
| +266% | +$419K |
|
2722
iShares MSCI Intl Quality Factor ETF
IQLT
$13B
| $577K | ﹤0.01% |
+13,900
| New | +$577K |
|
2723
SPDR S&P Semiconductor ETF
XSD
$1.48B
| $577K | ﹤0.01% |
2,400
+1,000
| +71% | +$240K |
|
2724
Virginia National Bankshares
VABK
$221M
| $575K | ﹤0.01% |
13,800
-5,800
| -30% | -$242K |
|
2725
Myomo
MYO
$31.9M
| $574K | ﹤0.01% |
143,100
+8,016
| +6% | +$32.1K |
|